Literature DB >> 7334408

Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change.

J A Royds, W R Timperley, C B Taylor.   

Abstract

The activities of enolase, aldolase, pyruvate kinase, lactate dehydrogenase and creatine phosphokinase were measured in cerebrospinal fluid of 121 patients presenting with a range of disorders of the central nervous system. The results from 41 patients undergoing myelography were used as controls. An assessment was made of the relative merits of these five enzymes as markers of brain damage with special reference to brain tumours. Enolase was the most sensitive marker of pathological change and was the only enzyme raised in the CSF of patients with low grade astrocytomas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7334408      PMCID: PMC491233          DOI: 10.1136/jnnp.44.12.1129

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  [Enzymatic activity of the cerebrospinal fluid in encephalic vasculopathies. Its diagnostic and prognostic interest].

Authors:  F Martínez Barrero; J M Nieto Vales; I Rodríguez Navarro
Journal:  Rev Clin Esp       Date:  1974-09-15       Impact factor: 1.556

2.  Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic, immunological and kinetic properties.

Authors:  C C Rider; C B Taylor
Journal:  Biochim Biophys Acta       Date:  1974-09-13

3.  The different adsorption of aldolase isoenzymes in rat brain.

Authors:  F M Clarke; C J Masters; D J Winzor
Journal:  Biochem J       Date:  1970-06       Impact factor: 3.857

4.  Lactate dehydrogenase and glutamic oxalacetic transaminase of the cerebrospinal fluid in neurological disease.

Authors:  G A Davies-Jones
Journal:  J Neurol Sci       Date:  1970-12       Impact factor: 3.181

5.  Cerebrospinal fluid enzymology: creatine kinase, lactate dehydrogenase activity and isozyme pattern as a brain damage index.

Authors:  J L Viallard; J Gaulme; B Dalens; B Dastugue
Journal:  Clin Chim Acta       Date:  1978-11-01       Impact factor: 3.786

6.  Diagnostic significance and source of lactate dehydrogenase and its isoenzymes in cerebrospinal fluid of children with a variety of neurological disorders.

Authors:  P V Nelson; W F Carey; A C Pollard
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

7.  Cerebrospinal fluid enzymes in acute brain injury. 3. Effect of hypotension on increase of CSF enzyme activity after cold injury in cats.

Authors:  A I Maas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-09       Impact factor: 10.154

8.  Immunoreactive aldolase C in cerebrospinal fluid of patients with neurological disorders.

Authors:  V J Willson; J G Graham; I N McQueen; R J Thompson
Journal:  Ann Clin Biochem       Date:  1980-05       Impact factor: 2.057

9.  SOME PROPERTIES OF FRUCTOSE 1,6-DIPHOSPHATASE OF RAT LIVER AND THEIR RELATION TO THE CONTROL OF GLUCONEOGENESIS.

Authors:  A H UNDERWOOD; E A NEWSHOLME
Journal:  Biochem J       Date:  1965-06       Impact factor: 3.857

Review 10.  Biochemical markers of central nervous system tumors measured in cerebrospinal fluid and their potential use in diagnosis and patient management: a review.

Authors:  J Seidenfeld; L J Marton
Journal:  J Natl Cancer Inst       Date:  1979-10       Impact factor: 13.506

  10 in total
  21 in total

1.  Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis.

Authors:  Y Sato; Y Honda; T Asoh; K Oizumi; Y Ohshima; E Honda
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

2.  HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.

Authors:  Seemana Bhattacharya; Mrinal K Ghosh
Journal:  Cell Oncol (Dordr)       Date:  2015-04-30       Impact factor: 6.730

3.  S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction.

Authors:  H G Hårdemark; O Almqvist; T Johansson; S Påhlman; L Persson
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

4.  Enzymatic changes in the cerebrospinal fluid as indices of pathological change.

Authors:  A Paşaoğlu; H Paşaoğlu
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

5.  Effects of chronic n-hexane exposure on nervous system-specific and muscle-specific proteins.

Authors:  J Huang; K Kato; E Shibata; K Sugimura; N Hisanaga; Y Ono; Y Takeuchi
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

6.  Functional Effects of Cigarette Smoke-Induced Changes in Airway Smooth Muscle Mitochondrial Morphology.

Authors:  Bharathi Aravamudan; Michael Thompson; Gary C Sieck; Robert Vassallo; Christina M Pabelick; Y S Prakash
Journal:  J Cell Physiol       Date:  2016-09-21       Impact factor: 6.384

7.  Neuron specific enolase (NSE) and thymidine kinase (TK) as markers in biological fluids of brain tumor patients.

Authors:  A Boiardi; L Munari; A Silvani; C L Solero; E Bombardieri
Journal:  Ital J Neurol Sci       Date:  1990-08

8.  The significance of neuron specific enolase levels in cerebrospinal fluid and serum after experimental traumatic brain damage.

Authors:  M Uzan; M Hanci; O Güzel; A C Sarioğlu; C Kuday; F Ozlen; M Y Kaynar
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 9.  Nonconvulsive status epilepticus in adults - insights into the invisible.

Authors:  Raoul Sutter; Saskia Semmlack; Peter W Kaplan
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

10.  Cerebrospinal fluid enolase in stroke.

Authors:  E Hay; J A Royds; G A Davies-Jones; N A Lewtas; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.